Thank you Roka - that was a very comprehensive and informative post.
I did not realise the subtle complexities of the trial - nor the shades of colour that may be revealed by the results.
It does make sense that the company not give info on secondary endpoints if they were inconclusive.
I was also interested in the explanation of the trials "power" and the company's justification for limiting enrollments to 193 patients - it all makes perfect economic sense.
The fact that there are four symptom clusters also means that analysis and release of results may not be as quick as I had formerly hoped.
Thanks again for that info - appreciated.
on a side issue - weird market in BNO yesterday - one minute knockingon teh door of 60c again then slammed back to 55c........
Does not seem like bots but rather an active strategy to stop a break back above 60c resistance level........
Cheers.
Cheers.
- Forums
- ASX - By Stock
- BNO
- Ann: Commencement of BNC210 Phase 2 Agitation Trial
Ann: Commencement of BNC210 Phase 2 Agitation Trial, page-34
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)